Skip to main content

Advertisement

SpringerLink
Log in

An Update on the Treatment of Lower Extremity Veins

  • Cosmetic Dermatology (JF Sobanko, Section Editor)
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

Abnormal leg veins such as varicose, reticular, and telangiectatic veins are a common complaint among adult patients and can often be a manifestation of underlying superficial venous hypertension and associated symptoms. Increasing age, obesity, pregnancy, hormonal factors, and the influence of prolonged sitting or standing can all play a role in promoting their development. The more factors that are present, the higher the likelihood for the development of leg veins. A number of therapeutic options are currently available for the treatment, including sclerotherapy and lasers for cutaneous veins and endovenous laser or radiofrequency ablation and ultrasound-guided sclerotherapy for subcutaneous sources of superficial venous reflux including incompetent truncal veins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Schwartz L, Maxwell H. Sclerotherapy for lower limb telangiectasias (review). Cochrane Database Syst Rev. 2011;12, CD008826. A comprehensive objective review of sclerotherapy for lower extremities.

    PubMed  Google Scholar 

  2. Nesbitt C, Eifell R, Coyne P, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for great saphenous vein varices (review). Cochrane Database Syst Rev. 2011;10, CD005624. A comprehensive review comparing treatment options for the treatment of great saphenous vein reflux.

    PubMed  Google Scholar 

  3. Gillespie D, Glass C. Importance of ultrasound evaluation in the diagnosis of venous insufficiency: guidelines and techniques. Semin Vasc Surg. 2010;23:85–9.

    Article  PubMed  Google Scholar 

  4. Oguzkurt L. Ultrasonographic anatomy of the lower extremity superficial veins. Diagn Interv Radiol. 2012;18:423–30.

    PubMed  Google Scholar 

  5. Goldman MP, Weiss RA, Bergan JJ. Diagnosis and treatment of varicose veins: a review. J Am Acad Dermatol. 1994;31:393–413.

    Article  CAS  PubMed  Google Scholar 

  6. Maurins U, Hoffmann BH, Lösch C, Jöckel KH, Rabe E, Pannier F. Distribution and prevalence of reflux in the superficial and deep venous system in the general population—results from the Bonn Vein Study, Germany. J Vasc Surg. 2008;48:680–7.

    Article  PubMed  Google Scholar 

  7. Meissner MH. Lower extremity venous anatomy. Semin Interv Radiol. 2005;22:147–56.

    Article  Google Scholar 

  8. Mozes G, Gloviczki P. New discoveries in anatomy and new terminology of leg veins: clinical implications. Vasc Endovasc Surg. 2004;38:367–74.

    Article  Google Scholar 

  9. Sadick NS. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol. 1992;18:883–6.

    Article  CAS  PubMed  Google Scholar 

  10. Weiss RA, Weiss MA. Doppler ultrasound findings in reticular veins of the thigh subdermic lateral venous system and implications for sclerotherapy. J Dermatol Surg Oncol. 1993;19:947–51.

    Article  CAS  PubMed  Google Scholar 

  11. Schuller-Petrović S, Pavlović MD, Schuller S, Schuller-Lukic B, Adamic M. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel. Phlebology. 2013;28:320–3.

    PubMed  Google Scholar 

  12. Khilnani NM, Min RJ. Duplex ultrasound for superficial venous insufficiency. Tech Vasc Interv Radiol. 2003;6:111–5.

    Article  PubMed  Google Scholar 

  13. Mechanism of action of sclerotherapy. In: Goldman MP, Guex JJ, Weiss RA, editors. Sclerotherapy: treatment of varicose and telangiectatic leg veins. 5th ed. Philadelphia: Saunders; 2011. p. 156–79.

  14. van Deurzen B, Ceulen RP, Tellings SS, van der Geld C, Nijsten T. Polidocanol concentration and time affect the properties of foam used for sclerotherapy. Dermatol Surg. 2011;37:1448–55.

    Article  Google Scholar 

  15. Duffy DM. Sclerosants: a comparative review. Dermatol Surg. 2010;36:1010–25.

    Article  CAS  PubMed  Google Scholar 

  16. Rao J, Goldman MP. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique. Dermatol Surg. 2005;31:19–22.

    Article  CAS  PubMed  Google Scholar 

  17. Peterson JD, Goldman MP. An investigation into the influence of various gases and concentrations of sclerosants on foam stability. Dermatol Surg. 2010;37:12–7.

    Article  PubMed  Google Scholar 

  18. Peterson JD, Goldman MP. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study. Phlebology. 2012;27:73–6. Clinical study demonstrating that carbon dioxide and air lead to equivalent efficacy when used for foam sclerotherapy.

    Article  CAS  PubMed  Google Scholar 

  19. Peterson JD, Goldman MP, Weiss RA, Duffy DM, Fabi SG, Weiss MA, et al. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 2012;38(8):1322–30. Clinical study demonstrating that although hypertonic saline and polidocanol have equivalent efficacy, the latter is associated with less injection-related pain and no post-treatment ulcerations.

    Article  CAS  PubMed  Google Scholar 

  20. Schuller-Petrović S, Pavlović MD, Neuhold N, Brunner F, Wölkart G. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy. J Eur Acad Dermatol Venereol. 2011;25:983–6.

    Article  PubMed  Google Scholar 

  21. Kern P, Ramelet AA, Wutschert R, Mazzolai L. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1 % lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins. Dermatol Surg. 2011;37:1590–4.

    Article  CAS  PubMed  Google Scholar 

  22. Goldman MP. How to utilize compression after sclerotherapy. Dermatol Surg. 2002;28(9):860–2.

    Article  PubMed  Google Scholar 

  23. Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am Acad Dermatol. 1987;17:167–82.

    Article  CAS  PubMed  Google Scholar 

  24. Schul MW, Eaton T, Erdman B. Compression versus sclerotherapy for patients with isolated refluxing reticular veins and telangiectasia: a randomized trial comparing quality-of-life outcomes. Phlebology. 2011;26:148–56. Patients with cutaneous leg veins and symptoms of venous disease can have significant symptomatic improvement with either compression or sclerotherapy; however, the latter leads to better results.

    Article  CAS  PubMed  Google Scholar 

  25. Meesters AA, Pitassi LHU, Campos V, Wolkerstorfer A, Dierickx CC. Transcutaneous laser treatment of leg veins. Lasers Med Sci. 2014;29:481–92.

    Google Scholar 

  26. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–7.

    Article  CAS  PubMed  Google Scholar 

  27. McCoppin HH, Hovenic WW, Wheeland RG. Laser treatment of superficial leg veins: a review. Dermatol Surg. 2011;37:729–41.

    Article  CAS  PubMed  Google Scholar 

  28. Ross EV, Domankevitz Y. Laser treatment of leg veins: physical mechanisms and theoretical considerations. Lasers Surg Med. 2005;36:105–16.

    Article  PubMed  Google Scholar 

  29. Klein A, Bäumler W, Koller M, Shafirstein G, Kohl EA, Landthaler M, et al. Indocyanine green-augmented diode laser therapy of telangiectatic leg veins: a randomized controlled proof-of-concept trial. Lasers Surg Med. 2012;44:369–76. Clinical study showing that intravenous dye (an exogenous chromophore) can potentiate the effect of lasers on leg veins.

    Article  PubMed  Google Scholar 

  30. Fodor L, Ramon Y, Fodor A, Carmi N, Peled IJ, Ullmann Y. A side-by-side prospective study of intense pulsed light and Nd:YAG laser treatment for vascular lesions. Ann Plast Surg. 2006;56:164–70.

    Article  CAS  PubMed  Google Scholar 

  31. Kunishige JH, Goldberg LH, Friedman PM. Laser therapy for leg veins. Clin Dermatol. 2007;25:454–61.

    Article  PubMed  Google Scholar 

  32. Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with the long-pulsed 1064 nm Nd:YAG laser. ScientificWorldJournal. 2012;2012:197139.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Ozden MG, Bahçivan M, Aydin F, Şentürk N, Bek Y, Cantürk T, et al. Clinical comparison of potassium-titanyl-phosphate (KTP) versus neodymium:YAG (Nd:YAG) laser treatment for lower extremity telangiectases. J Dermatol Treat. 2011;22:162–6.

    Article  Google Scholar 

  34. Mordon S, Brisot D, Fournier N. Using a “non uniform pulse sequence” can improve selective coagulation with a Nd:YAG laser (1.06 microm) thanks to Met-hemoglobin absorption: a clinical study on blue leg veins. Lasers Surg Med. 2003;32:160–70.

    Article  PubMed  Google Scholar 

  35. Trelles MA, Weiss R, Moreno-Moragas J, Romero C, Vélez M, Alvarez X. Treatment of leg veins with combined pulsed dye and Nd:YAG lasers: 60 patients assessed at 6 months. Lasers Surg Med. 2010;42:609–14.

    Article  PubMed  Google Scholar 

  36. Tepavcevic B, Matic P, Radak D. Comparison of sclerotherapy, laser, and radiowave coagulation in treatment of lower extremity telangiectasias. J Cosmet Laser Ther. 2012;14:239–42.

    Article  PubMed  Google Scholar 

  37. Munia MA, Wolosker N, Munia CG, Chao WS, Puech-Leão P. Comparison of laser versus sclerotherapy in the treatment of lower extremity telangiectases: a prospective study. Dermatol Surg. 2011;38:635–9.

    Article  PubMed  Google Scholar 

  38. Moreno-Moraga J, Smarandache A, Pascu ML, Royo J, Trelles MA. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Phlebology. 2013. doi:10.1177/0268355513502786. Clinical study demonstrating that the combination of Nd:YAG laser with sclerotherapy is more effective for leg veins.

  39. Moreno-Moraga J, Hernández E, Royo J, Alcolea J, Isarría MJ, Pascu ML, et al. Optimal and safe treatment of spider leg veins measuring less than 1.5 mm on skin type IV patients, using repeated low-fluence Nd:YAG laser pulses after polidocanol injection. Lasers Med Sci. 2012;28:925–33.

    Article  PubMed  Google Scholar 

  40. Goldman MP, Fitzpatrick RE. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy. J Dermatol Surg Oncol. 1990;16:338–44.

    Article  CAS  PubMed  Google Scholar 

  41. Brown K, Moore CJ. Update on the treatment of saphenous reflux: laser, RFA or foam? Perspect Vasc Surg Endovasc Ther. 2010;21:226–31.

    Article  Google Scholar 

  42. Siribumrungwong B, Noorit P, Wilasrusmee C, Attia J, Thakkinstian A. A systematic review and meta-analysis of randomised controlled trials comparing endovenous ablation and surgical intervention in patients with varicose vein. Eur J Vasc Endovasc Surg. 2012;44:214–23.

    Article  CAS  PubMed  Google Scholar 

  43. Kelleher D, Lane TRA, Franklin IJ, Davies AH. Socio-economic impact of endovenous thermal ablation techniques. Lasers Med Sci. 2014;29:493–99.

    Google Scholar 

  44. Kalra M, Gloviczki P. Endovenous ablation of the saphenous vein. Perspect Vasc Surg Endovasc Ther. 2008;20:371–80.

    Article  PubMed  Google Scholar 

  45. van den Bos RR, Proebstle TM. The state of the art of endothermal ablation. Lasers Med Sci. 2013. doi:10.1007/s10103-013-1448-5.

  46. Nijsten T, van den Bos RR, Goldman MP, Kockaert MA, Proebstle TM, Rabe E, et al. Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol. 2009;60:110–9.

    Article  PubMed  Google Scholar 

  47. Harlander-Locke M, Jimenez JC, Lawrence PF, Derubertis BG, Rigberg DA, Gelabert HA. Endovenous ablation with concomitant phlebectomy is a safe and effective method of treatment for symptomatic patients with axial reflux and large incompetent tributaries. J Vasc Surg. 2013;58:166–72. Clinical study highlighting the need for phlebectomy in addition to endovenous closures for varicose veins.

    Article  PubMed  Google Scholar 

  48. Biemans AAM, Kockaert M, Akkersdijk GP, van den Bos RR, de Maeseneer MGR, Cuypers P, et al. Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg. 2013;58:727–34. Clinical study highlighting that endovenous laser ablation likely leads to greater long term closure rates than ultrasound-guided foam sclerotherapy.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Daniel P. Friedmann has received a grant from the American Society for Dermatologic Surgery.

Ana Marie Liolios declares no conflicts of interest.

Mitchel P. Goldman has received consultant fees from Merz.

Human and Animal Rights and Informed Consent

All studies by the authors involving animal and/or human subjects were performed after approval by the appropriate institutional review boards. When required, a written informed consent was obtained from all participants.

Author information

Authors and Affiliations

  1. Westlake Dermatology Clinical Research Center, 8825 Bee Cave Rd, Ste 100, Austin, TX, 78746, USA

    Daniel P. Friedmann

  2. Goldman, Butterwick, Fitzpatrick, Groff & Fabi: Cosmetic Laser Dermatology, 9339 Genesee Ave, Ste 300, San Diego, CA, 92121, USA

    Ana Marie Liolios & Mitchel P. Goldman

Authors
  1. Daniel P. Friedmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Marie Liolios
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mitchel P. Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel P. Friedmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedmann, D.P., Liolios, A.M. & Goldman, M.P. An Update on the Treatment of Lower Extremity Veins. Curr Derm Rep 3, 113–121 (2014). https://doi.org/10.1007/s13671-014-0077-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-014-0077-y

Keywords

Search

Navigation